Totally agree, and reading the transcript of Bausch 's conference it's easy to realise that BOT would be perfectly positioned for acquisition on positive trial's results in that it'll have an eyes watering product pipeline, ripe and ready for inclusion in their R&D portfolio.
Totally agree, and reading the transcript of Bausch 's...
-
- There are more pages in this discussion • 195 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.0¢ | $843.9K | 2.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 76260 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 149185 | 4 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
